FDA Approves Keytruda For A New Type of Cancer
The U.S. Food and Drug Administration (FDA) has approved the drug Keytruda for patients with head and neck squamous cell carcinoma (HNSCC).
Category: Merck
FDA-Approved Keytruda Treatment Could Help Mesothelioma Patients
Recently, the FDA approved Merck immunotherapy drug Keytruda for treatment in non-small cell lung cancer and is bringing hope to mesothelioma patients.
Can Opdivo Drug Be Good News for Mesothelioma Patients?
Expanded approved use of new lung cancer drug Opdivo could give malignant pleural mesothelioma patients hope.